Traffic:
10E
10W
15N
15S
57N
57S
60E
60W
210E
210W
This Site
Web Search
powered by
YAHOO! SEARCH
Subscriber Services
|
Home Delivery
|
e-Edition
|
Alerts
|
RSS
Home
News
Ontario
Rancho Cucamonga
Pomona
Upland
Claremont
Montclair
Chino Valley
California
Crime & Public Safety
Elections
Education
S.B. County Watch
Upland Watch
I.E.: Medicare Testing Ground
Sports
Buy Event Tickets Now
Golf - Tee Times and Courses
Preps
Reign Hockey
Rancho Cucamonga Quakes
Local Colleges
USC
UCLA
Lakers
Clippers
Dodgers
Angels
Ducks
Soccer
Motor Sports
Horse Racing
Live Odds
Business
Autos
Real Estate News
Technology
Opinions
Editorial
Letters
Columnists
Blogs
LA.COM
Buy Tickets
Movies
TV
Music
Shopping & Beauty
Recreation
Neighborhood
Arts
Living
Dining
Find A Restaurant
Lottery
Horoscopes
Travel
Trevor's Travels
Health
Crossword Puzzle
Local Casinos
Foothills Magazine
Info
Subscribe For Home Delivery
Contact Us
RSS
Podcast
Subscriber Services
Place An Ad
NIE
Classified
Place an Ad
Homes
Jobs
Auto
Search autos
Buy/Sell a car
Research/Financing a car
Find a dealer
Shopping
This week's ads
Obits
Directories
Local Business
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
(OP:
POLBF
)
0.1510
UNCHANGED
Last Price
Updated: 9:30 AM EDT, Aug 1, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
0.1510
Bid (Size)
N/A (0)
Ask (Size)
N/A (0)
Prev. Close
0.1510
Today's Range
0.1510 - 0.1510
52wk Range
0.1070 - 0.2269
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Poolbeg Pharma PLC Announces Voluntary Delisting from OTCQB Market
July 25, 2024
Via
ACCESSWIRE
Poolbeg Pharma PLC Announces Change of Registered Address
July 01, 2024
Via
ACCESSWIRE
Performance
YTD
+41.12%
+41.12%
1 Month
N/A
N/A
3 Month
-15.17%
-15.17%
6 Month
+37.27%
+37.27%
1 Year
+41.12%
+41.12%
More News
Read More
Poolbeg Pharma PLC Announces Annual Report & AGM Notice
May 08, 2024
Via
ACCESSWIRE
Poolbeg Pharma's POLB 001 immuno-modulator II receives fully-granted patent from US Patent Office
May 08, 2024
Via
News Direct
Topics
Intellectual Property
Exposures
Intellectual Property
Poolbeg Pharma's POLB 001 immuno-modulator II receives fully-granted patent from US Patent Office
May 08, 2024
Via
TheNewswire.com
Topics
Intellectual Property
Exposures
Intellectual Property
Poolbeg Pharma PLC Announces Significant POLB 001 Patent Granted in USA
April 30, 2024
Via
ACCESSWIRE
Poolbeg Pharma PLC Announces Results for the Year Ended 31 December 2023
April 29, 2024
Via
ACCESSWIRE
Poolbeg Pharma PLC Announces Option Agreement to Acquire Orphan Drug Candidate
April 29, 2024
Via
ACCESSWIRE
Poolbeg Pharma PLC Announces TR-1: Notification of Major Holdings
April 28, 2024
Via
ACCESSWIRE
Poolbeg Pharma PLC Announces Appointment of Joint Broker
April 29, 2024
Via
ACCESSWIRE
Poolbeg Pharma PLC Announces POLB 001 US Patent Update
March 19, 2024
Via
ACCESSWIRE
Poolbeg Pharma PLC Announces Director Share Purchase
February 19, 2024
Via
ACCESSWIRE
Poolbeg Pharma PLC Announces POLB 001 Data Presented at ASH
December 11, 2023
Via
ACCESSWIRE
Poolbeg Pharma PLC Announces Directorate Change
November 30, 2023
Via
ACCESSWIRE
Poolbeg Pharma PLC Announces Immunomodulator II Patent Granted in Japan
November 21, 2023
Via
ACCESSWIRE
Poolbeg Pharma PLC Announces POLB 001 LPS Trial Data to be Presented at IUIS
November 16, 2023
Via
ACCESSWIRE
Former Amryt Pharma Leadership Team join Poolbeg
November 09, 2023
Via
ACCESSWIRE
Poolbeg Pharma PLC Announces POLB 001 Data to be Presented at American Society of Hematology Annual Meeting
November 03, 2023
Via
ACCESSWIRE
Poolbeg Pharma PLC Announces Board Role Change and Launch of EIP
February 14, 2024
Via
ACCESSWIRE
Poolbeg Pharma PLC Announces Market Opportunity for POLB 001 for CRS
February 11, 2024
Via
ACCESSWIRE
Poolbeg Pharma PLC Announces Further Data Shows POLB001 Potential in Cancer CRS
January 16, 2024
Via
ACCESSWIRE
Poolbeg Pharma PLC Announces RSV AI Drug Candidate Analysis Update
December 19, 2023
Via
ACCESSWIRE
Poolbeg Pharma PLC Announces POLB 001 Oncology Programme Update Meeting
November 01, 2023
Via
ACCESSWIRE
Poolbeg Pharma unveils new collaboration agreement
October 18, 2023
Via
News Direct
Poolbeg Pharma unveils new collaboration agreement
October 18, 2023
Via
TheNewswire.com
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Privacy Policy
|
Terms of Use
|
MNG Corporate Site Map
|
Copyright